These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3275494)

  • 21. Does fundoplication change the risk of esophageal cancer in the setting of GERD?
    Shaheen NJ
    Am J Gastroenterol; 2005 May; 100(5):1009-11. PubMed ID: 15842571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardization of immunobioassays as surrogate endpoints.
    Masood S
    J Cell Biochem Suppl; 1994; 19():28-35. PubMed ID: 7823602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis, screening and follow-up of gastrointestinal cancer.
    Zfass AM
    Med Sect Proc; 1987; ():77-91. PubMed ID: 3452832
    [No Abstract]   [Full Text] [Related]  

  • 25. The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer.
    Schulze G
    Anticancer Res; 2000; 20(6D):4961-4. PubMed ID: 11326647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer.
    Hu N; Roth MJ; Emmert-Buck MR; Tang ZZ; Polymeropolous M; Wang QH; Goldstein AM; Han XY; Dawsey SM; Ding T; Giffen C; Taylor PR
    Clin Cancer Res; 1999 Nov; 5(11):3476-82. PubMed ID: 10589761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and gene expression in esophageal cancer.
    Xu XC
    Methods Mol Biol; 2009; 471():335-60. PubMed ID: 19109788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories.
    Rothman N; Stewart WF; Schulte PA
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):301-11. PubMed ID: 7655323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Esophagus, stomach, liver, pancreas carcinoma. What recommendations for prevention?].
    Schoppmeyer K; Mössner J
    MMW Fortschr Med; 2003 Apr; 145(16):30-3, 35. PubMed ID: 14606399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations.
    Verma M; Manne U
    Crit Rev Oncol Hematol; 2006 Oct; 60(1):9-18. PubMed ID: 16829121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diet and cancer: assessing the risk.
    Gill CI; Rowland IR
    Br J Nutr; 2002 Sep; 88 Suppl 1():S73-87. PubMed ID: 12215186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purified and endogenous phytic acid in wheat bran affects early biomarkers of colon cancer risk.
    Jenab M; Thompson LU
    IARC Sci Publ; 2002; 156():387-9. PubMed ID: 12484214
    [No Abstract]   [Full Text] [Related]  

  • 33. [Many tumors in the digestive tract can be prevented. Focus on motivation for prevention].
    Füessl HS
    MMW Fortschr Med; 2003 Apr; 145(16):29. PubMed ID: 14606398
    [No Abstract]   [Full Text] [Related]  

  • 34. Socioeconomic position and the risk of gastric and oesophageal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
    Nagel G; Linseisen J; Boshuizen HC; Pera G; Del Giudice G; Westert GP; Bueno-de-Mesquita HB; Allen NE; Key TJ; Numans ME; Peeters PH; Sieri S; Siman H; Berglund G; Hallmans G; Stenling R; Martinez C; Arriola L; Barricarte A; Chirlaque MD; Quiros JR; Vineis P; Masala G; Palli D; Panico S; Tumino R; Bingham S; Boeing H; Bergmann MM; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Olsen A; Tjonneland A; Trichopoulou A; Bamia C; Soukara S; Sabourin JC; Carneiro F; Slimani N; Jenab M; Norat T; Riboli E; González CA
    Int J Epidemiol; 2007 Feb; 36(1):66-76. PubMed ID: 17227779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alarming increase of esophageal cancer. Is antireflux surgery an efficient prevention?].
    Lundell L
    Lakartidningen; 2000 Dec; 97(51-52):6016-20. PubMed ID: 11195438
    [No Abstract]   [Full Text] [Related]  

  • 36. Flavonoids and intestinal cancers.
    Pierini R; Gee JM; Belshaw NJ; Johnson IT
    Br J Nutr; 2008 May; 99 E Suppl 1():ES53-9. PubMed ID: 18503735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cancer-risk diseases of the gastrointestinal tract].
    Schwamberger K; Reissigl H; Aigner F
    ZFA (Stuttgart); 1981 Sep; 57(27):1796-9. PubMed ID: 7345813
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reflux, smoking, alcohol. Approach to prevention of esophageal carcinoma].
    Rotthauwe J; Lingenfelser T; Malfertheiner P
    MMW Fortschr Med; 2002 Jul; 144(27-28):26-31. PubMed ID: 12198874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esophageal cancer: epidemiology, pathogenesis and prevention.
    Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):517-26. PubMed ID: 18679388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials.
    Hemstreet GP; Rao J; Hurst RE; Bonner RB; Waliszewski P; Grossman HB; Liebert M; Bane BL
    J Cell Biochem Suppl; 1996; 25():197-204. PubMed ID: 9027619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.